| Role |
Name |
Disclosure |
Details |
| Author | Carlos A Camargo Jr, MD, MPH, DrPH, Director, EMNet Coordinating Center; Associate Professor of Medicine & Epidemiology, Harvard Medical School; Consulting Staff, Department of Emergency Medicine, Massachusetts General Hospital | AstraZeneca Critical Therapeutics Dey Genentech GSK Merck Novartis Respironics Schering-Plough | Details | | Coauthor | Barry E Brenner, MD, PhD, FACEP, Program Director, Professor, Department of Emergency Medicine, Professor, Internal Medicine, University Hospitals, Case Western Reserve School of Medicine | Nothing to disclose | Details | | Medical Editor | Edward Bessman, MD, Chairman, Department of Emergency Medicine, John Hopkins Bayview Medical Center; Assistant Professor, Department of Emergency Medicine, Johns Hopkins University | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Paul Blackburn, DO, FACOEP, FACEP, Program Director, Department of Emergency Medicine, Maricopa Medical Center; Assistant Professor, Department of Surgery, University of Arizona | Nothing to disclose | Details | | CME Editor | John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center | Nothing to disclose | Details | | Chief Editor | Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School | eMedicine.com, Inc. | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Paul Blackburn, Managing Editor |
The contributor discloses no conflict of interest. |
|